• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒病 2019(COVID-19)全面综述。

Comprehensive review of coronavirus disease 2019 (COVID-19).

机构信息

Department of Internal Medicine, Geisinger Commonwealth School of Medicine, PA, USA.

出版信息

Biomed J. 2020 Aug;43(4):334-340. doi: 10.1016/j.bj.2020.05.023. Epub 2020 Jun 1.

DOI:10.1016/j.bj.2020.05.023
PMID:32788071
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7263230/
Abstract

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in December 2019 in Wuhan, the capital of China's Hubei province and has rapidly spread all over the world. The World Health Organization (WHO) declared the outbreak to be a Public Health Emergency of International Concern on 01/30/2020 and recognized it as a pandemic on 03/11/2020. The number of people diagnosed with COVID-19 worldwide crossed the one million mark on 04/02/2020; two million mark on 04/15/2020; three million mark on 04/27/2020 and the four million mark on 05/09/2020. Despite containment efforts, more than 187 countries have been affected with more than 4,178,346 cases in the world with maximum being in USA (1,347,936) followed by 227,436 in Spain and 224,422 in United Kingdom as of May, 2020. COVID-19 is the latest threat to face mankind cutting across geographical barriers in a rapidly changing landscape. This review provides an update on a rapidly evolving global pandemic. As we face the threat of emerging and re-emerging infectious diseases, this is a stark reminder to invest in population health, climate change countermeasures, a global health surveillance system and effective research into identifying pathogens, their treatment and prevention and effective health delivery systems.

摘要

新型冠状病毒病(COVID-19)由严重急性呼吸系统综合症冠状病毒 2 型(SARS-CoV-2)引起,于 2019 年 12 月在中国湖北省省会武汉首次被鉴定,现已迅速在全球蔓延。世界卫生组织(WHO)于 2020 年 1 月 30 日宣布疫情为国际关注的突发公共卫生事件,并于 2020 年 3 月 11 日宣布其为大流行。全球确诊 COVID-19 人数于 2020 年 4 月 2 日突破一百万;4 月 15 日突破两百万;4 月 27 日突破三百万;5 月 9 日突破四百万。尽管采取了遏制措施,但仍有超过 187 个国家受到影响,全球有超过 4178346 例病例,其中美国最多(1347936 例),其次是西班牙(227436 例)和英国(224422 例)。截至 2020 年 5 月。COVID-19 是人类面临的最新威胁,跨越了地理界限,在迅速变化的环境中蔓延。本综述提供了对迅速演变的全球大流行的最新更新。由于我们面临新出现和重新出现的传染病的威胁,这强烈提醒我们要投资于人口健康、气候变化对策、全球卫生监测系统以及有效研究以确定病原体、其治疗和预防以及有效的卫生提供系统。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c351/7567761/dc64a97d3073/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c351/7567761/d53b55a27698/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c351/7567761/8fbdd833bbfa/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c351/7567761/dc64a97d3073/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c351/7567761/d53b55a27698/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c351/7567761/8fbdd833bbfa/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c351/7567761/dc64a97d3073/gr3.jpg

相似文献

1
Comprehensive review of coronavirus disease 2019 (COVID-19).新型冠状病毒病 2019(COVID-19)全面综述。
Biomed J. 2020 Aug;43(4):334-340. doi: 10.1016/j.bj.2020.05.023. Epub 2020 Jun 1.
2
Occupational health responses to COVID-19: What lessons can we learn from SARS?职业健康对 COVID-19 的应对:我们能从 SARS 中学到什么教训?
J Occup Health. 2020 Jan;62(1):e12128. doi: 10.1002/1348-9585.12128.
3
Coronavirus disease 2019 (COVID-19): A literature review.新型冠状病毒病 2019(COVID-19):文献综述。
J Infect Public Health. 2020 May;13(5):667-673. doi: 10.1016/j.jiph.2020.03.019. Epub 2020 Apr 8.
4
Update: Public Health Response to the Coronavirus Disease 2019 Outbreak - United States, February 24, 2020.更新:美国 2020 年 2 月 24 日针对 2019 年冠状病毒病疫情的公共卫生应对措施。
MMWR Morb Mortal Wkly Rep. 2020 Feb 28;69(8):216-219. doi: 10.15585/mmwr.mm6908e1.
5
The outbreak of Coronavirus Disease 2019 (COVID-19)-An emerging global health threat.2019 年冠状病毒病(COVID-19)爆发-新兴的全球健康威胁。
J Infect Public Health. 2020 Apr;13(4):644-646. doi: 10.1016/j.jiph.2020.02.033. Epub 2020 Mar 19.
6
A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group.新型冠状病毒病 2019(COVID-19)大流行期间癌症患者管理的实用方法:国际协作组。
Oncologist. 2020 Jun;25(6):e936-e945. doi: 10.1634/theoncologist.2020-0213. Epub 2020 Apr 27.
7
Geographical tracking and mapping of coronavirus disease COVID-19/severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events around the world: how 21st century GIS technologies are supporting the global fight against outbreaks and epidemics.全球冠状病毒病 COVID-19/严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)疫情及相关事件的地理追踪和制图:21 世纪 GIS 技术如何支持全球抗击疫情和传染病。
Int J Health Geogr. 2020 Mar 11;19(1):8. doi: 10.1186/s12942-020-00202-8.
8
COVID-19-A Novel Zoonotic Disease: A Review of the Disease, the Virus, and Public Health Measures.COVID-19 新型人畜共患病:疾病、病毒和公共卫生措施综述。
Asia Pac J Public Health. 2020 May;32(4):145-153. doi: 10.1177/1010539520931326. Epub 2020 May 30.
9
The novel zoonotic COVID-19 pandemic: An expected global health concern.新型人畜共患的新冠疫情:一个意料之中的全球卫生问题。
J Infect Dev Ctries. 2020 Mar 31;14(3):254-264. doi: 10.3855/jidc.12671.
10
Response to the COVID-19 Epidemic: The Chinese Experience and Implications for Other Countries.应对 COVID-19 疫情:中国的经验及其对其他国家的启示。
Int J Environ Res Public Health. 2020 Mar 30;17(7):2304. doi: 10.3390/ijerph17072304.

引用本文的文献

1
Comparative analysis of candidal carriage rates in long-term and short-term COVID-19 patients: An RT-PCR study.长期和短期新冠肺炎患者念珠菌携带率的比较分析:一项逆转录聚合酶链反应研究
J Oral Biol Craniofac Res. 2025 Jul-Aug;15(4):899-904. doi: 10.1016/j.jobcr.2025.06.014. Epub 2025 Jun 16.
2
The Negative Impact of Social Media during COVID-19 Pandemic.新冠疫情期间社交媒体的负面影响
Trends Psychol. 2023;31(1):123-142. doi: 10.1007/s43076-022-00192-5. Epub 2022 May 16.
3
An Approach to, and Tool for, Predicting the Time Course of an Infectious Disease Outbreak as a Function of Behavioral Interventions.

本文引用的文献

1
On the origin and continuing evolution of SARS-CoV-2.关于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的起源及持续进化
Natl Sci Rev. 2020 Jun;7(6):1012-1023. doi: 10.1093/nsr/nwaa036. Epub 2020 Mar 3.
2
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations.2019 冠状病毒病(COVID-19)的重症监护管理:挑战与建议。
Lancet Respir Med. 2020 May;8(5):506-517. doi: 10.1016/S2213-2600(20)30161-2. Epub 2020 Apr 6.
3
Effectiveness of convalescent plasma therapy in severe COVID-19 patients.恢复期血浆疗法治疗重症 COVID-19 患者的疗效。
一种将传染病爆发的时间进程预测为行为干预函数的方法及工具。
Infect Drug Resist. 2025 May 30;18:2717-2729. doi: 10.2147/IDR.S501934. eCollection 2025.
4
Long-Term Effects of COVID-19 on Women's Reproductive Health and Its Association with Autoimmune Diseases, Including Multiple Sclerosis.新冠病毒病对女性生殖健康的长期影响及其与自身免疫性疾病(包括多发性硬化症)的关联
J Clin Med. 2025 Apr 29;14(9):3057. doi: 10.3390/jcm14093057.
5
Impact of COVID-19 on Renal Transplant Recipients in a National Transplant Center.新型冠状病毒肺炎对一家国家移植中心肾移植受者的影响
Immun Inflamm Dis. 2025 Apr;13(4):e70187. doi: 10.1002/iid3.70187.
6
Severe Asthma and Active SARS-CoV-2 Infection: Insights into Biologics.重症哮喘与活动性SARS-CoV-2感染:生物制剂的见解
Biomedicines. 2025 Mar 10;13(3):674. doi: 10.3390/biomedicines13030674.
7
The Effect of Inhaled Ozone Therapy in Two-Hit Rat Model of Lipopolysaccharides-Induced Acute Lung Injury and Bleomycin-Induced Pulmonary Fibrosis.吸入臭氧疗法对脂多糖诱导的急性肺损伤和博来霉素诱导的肺纤维化双打击大鼠模型的影响
Protein J. 2025 Feb 7. doi: 10.1007/s10930-024-10247-4.
8
Investigating the effectiveness of whole-virus, protein-based, and vector-based SARS-CoV-2 vaccines on the rates of COVID-19 infection, hospitalization, and mortality: a historical cohort study in Iran.研究全病毒、基于蛋白质和基于载体的新冠病毒疫苗对新冠病毒感染率、住院率和死亡率的有效性:伊朗的一项历史性队列研究。
BMC Infect Dis. 2025 Jan 9;25(1):44. doi: 10.1186/s12879-025-10449-w.
9
The psychological impact of COVID-19 on front-line healthcare providers in the United Arab Emirates: A cross-sectional study.COVID-19对阿联酋一线医护人员的心理影响:一项横断面研究。
J Educ Health Promot. 2024 Sep 28;13:335. doi: 10.4103/jehp.jehp_1734_23. eCollection 2024.
10
Docking heparan sulfate-based ligands as a promising inhibitor for SARS-CoV-2.对接基于硫酸乙酰肝素的配体作为一种有前景的新型冠状病毒抑制剂。
J Mol Model. 2024 Dec 12;31(1):19. doi: 10.1007/s00894-024-06236-0.
Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496. doi: 10.1073/pnas.2004168117. Epub 2020 Apr 6.
4
Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins.鉴定马来穿山甲体内的 SARS-CoV-2 相关冠状病毒
Nature. 2020 Jul;583(7815):282-285. doi: 10.1038/s41586-020-2169-0. Epub 2020 Mar 26.
5
Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn.可能存在感染 SARS-CoV-2 的母亲将病毒垂直传播给新生儿的情况。
JAMA. 2020 May 12;323(18):1846-1848. doi: 10.1001/jama.2020.4621.
6
Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020.2020 年 2 月 12 日至 3 月 16 日,美国 2019 冠状病毒病(COVID-19)患者的严重结局。
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346. doi: 10.15585/mmwr.mm6912e2.
7
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.与严重急性呼吸综合征冠状病毒1(SARS-CoV-1)相比,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)在气溶胶和表面的稳定性
N Engl J Med. 2020 Apr 16;382(16):1564-1567. doi: 10.1056/NEJMc2004973. Epub 2020 Mar 17.
8
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application.新型冠状病毒肺炎(COVID-19)的潜伏期来自公开报告的确诊病例:估计和应用。
Ann Intern Med. 2020 May 5;172(9):577-582. doi: 10.7326/M20-0504. Epub 2020 Mar 10.
9
Evidence for Gastrointestinal Infection of SARS-CoV-2.新型冠状病毒2019(SARS-CoV-2)胃肠道感染的证据。
Gastroenterology. 2020 May;158(6):1831-1833.e3. doi: 10.1053/j.gastro.2020.02.055. Epub 2020 Mar 3.
10
COVID-19 and the cardiovascular system.新型冠状病毒肺炎与心血管系统。
Nat Rev Cardiol. 2020 May;17(5):259-260. doi: 10.1038/s41569-020-0360-5.